Success Stories: EB-1A Approved for a Resident in Ohio in the Field of Urologic Oncology
Client’s Testimonial:
Thanks a lot for your help! You guys were excellent. I have already referred some of my friends.
We Received EB1-A (Alien of Extraordinary Ability) Approval on October 15th, 2014 for a Resident in Ohio in the Field of Urology (Approval Notice)
Position at the Time of Case Filing: Resident
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Ohio
Approval Notice Date: October 15th, 2014
Processing Time: 4 Months, 6 Days
In this case, the client that we had the pleasure of working with was a Resident from India in the field of Urology. His specialized research has focused on alternative methods of surgical treatment of urologic cancers like cryoablation, or the application of extreme cold to induce localized cell death. His work had resulted in at least 18 peer-reviewed journal articles, published abstracts, and numerous conference publications. At the time that his case was filed, his publications had been cited at least 115 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 16 manuscript reviews for at least 6 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from a recommender, “[Client]’s findings have formed the foundation of a clinical trial carried out by his associates in post treatment prostate cancer patients who have recurrence of their cancer as determined by rise in Prostate-Specific Antigen, the marker of prostate cancer[…..] [Client] has been recognized as a leader in urologic research and his work is influential to that of his peers.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Urology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 6 days.